A heritage Psilocybe cubensis lineage originating in the Huautla de Jiménez region of Oaxaca — the site of R. Gordon Wasson's 1955 velada with the Mazatec curandera María Sabina.
§ 01Morphology
Huautla produces mid-sized fruits with caramel-to-reddish-brown caps of 30–70 mm. The stipe is moderate in thickness and length, bruising a clear blue-green on handling. Specimen variability is higher than in strongly stabilised modern lines — a trait consistent with the variety's origin as a regional population rather than a single-founder isolate.
Veil remnants often persist on the stipe after cap expansion, and spore prints mature to the standard deep purple-black. Cap surfaces can appear minutely striate at the margin under magnification.
§ 02Origin & Naming
The variety is named for the Huautla de Jiménez region of the Sierra Mazateca in Oaxaca, Mexico — the historical site of the most extensively documented instance of pre-Columbian ethnomycological practice. R. Gordon Wasson's 1955 velada with María Sabina, published in Life magazine in May 1957, was the founding Western account of psilocybin use and led to the species' entry into pharmaceutical research.
Cultivated Huautla stocks derive from spore collections by subsequent visitors to the region, principally during the 1960s and 70s. The cultivated material should be regarded as regionally descended rather than strictly identical to any single wild collection.
§ 03Cultivation Temperament
Huautla displays broad environmental tolerance comparable to its regional neighbour Mazatapec, reflecting shared adaptation to the Sierra Mazateca's sub-tropical montane climate. Fruiting temperature range is broad (20–27 °C), colonisation is moderate, and flushes are reliable if not record-setting.
The variety is considered moderately forgiving for novice cultivators but is typically recommended after initial experience with a stabilised modern line such as Golden Teacher or B+. Yields are average on a per-weight basis; specimen consistency improves markedly under tight environmental control.
§ 04Safety Profile
As with all psilocybin-containing species, Huautla carries significant contraindications. Psilocybin is a serotonergic compound and interacts with a range of medications and mental-health conditions.
⚠ Contraindications
Not suitable for individuals with personal or family history of psychotic disorders, schizophrenia, or bipolar I; those taking SSRIs, MAOIs, or lithium; pregnant or breastfeeding persons; or those with unmanaged cardiovascular conditions. Always review the full safety codex before use.